Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Neumora Therapeutics, Inc. - Common Stock
(NQ:
NMRA
)
2.060
-0.040 (-1.90%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Neumora Therapeutics, Inc. - Common Stock
< Previous
1
2
3
Next >
This Fund Put $3.4 Million Into Navan Despite a 60% Post-IPO Drop
↗
January 24, 2026
Navan delivers AI-powered travel and expense management software for enterprise clients seeking streamlined operations.
Via
The Motley Fool
Topics
Artificial Intelligence
Initial Public Offering
Regulatory Compliance
Top movers in Tuesday's pre-market session
↗
December 23, 2025
As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Unusual volume stocks in Thursday's session
↗
October 30, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Unusual volume stocks in Wednesday's session
↗
October 29, 2025
In today's session, these stocks are experiencing unusual volume.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 27, 2025
Via
Benzinga
Neumora Therapeutics’ Experimental Drug Demonstrates Weight Loss in Preclinical Studies
↗
October 27, 2025
Neumora said that NMRA-215 demonstrated weight loss of up to 19% as a monotherapy and 26% in combination with Semaglutide.
Via
Stocktwits
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 23, 2025
Via
Benzinga
This Warner Bros. Discovery Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
↗
September 16, 2025
Via
Benzinga
Neumora (NMRA) Q2 Loss Improves 10%
↗
August 06, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 28, 2025
Via
Benzinga
Boston Beer Posts Better-Than-Expected Earnings, Joins Scholastic, Deckers Outdoor, Saia And Other Big Stocks Moving Higher On Friday
↗
July 25, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 18, 2025
Via
Benzinga
These stocks are moving in today's session
↗
July 09, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
June 09, 2025
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
↗
May 19, 2025
Via
Benzinga
Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'
↗
March 07, 2025
Johnson & Johnson discontinues aticaprant's Phase 3 trial but explores future options. Another depression drug Spravato sales hit $1.01 billion
Via
Benzinga
Rivian Automotive, Cerence, Nu Skin Enterprises And Other Big Stocks Moving Higher On Friday
↗
January 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
January 02, 2025
Via
Benzinga
Crude Oil Surges 2%; Tesla Shares Plummet
↗
January 02, 2025
Via
Benzinga
Nasdaq Dips Over 100 Points; Unity Software Shares Jump
↗
January 02, 2025
Via
Benzinga
Dow Surges Over 300 Points; US Initial Jobless Claims Decline
↗
January 02, 2025
Via
Benzinga
Topics
Stocks
Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops
↗
January 02, 2025
The company said it plans to investigate a positive signal from female patients.
Via
Investor's Business Daily
Neumora Therapeutics, XPeng And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
January 02, 2025
Via
Benzinga
Neumora Therapeutics Depression Drug Fails In First Of Three Pivotal Phase 3 Trials
↗
January 02, 2025
Neumora's KOASTAL-1 study results show navacaprant missed key goals in major depressive disorder. Additional studies and updates are anticipated.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 18, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 02, 2024
Via
Benzinga
This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
↗
November 05, 2024
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
